Recently, China’s new crown vaccines have been widely reported. Phase III clinical trials of several vaccines have been carried out smoothly in foreign countries.
On December 31 last year, Sinopharm China biological new crown inactivated vaccine was approved for conditional marketing.
Countries around the world are lining up to buy Chinese vaccines.
On December 2, 2020, Egypt officially approved the emergency use of Sinopharm’s new crown inactivated vaccine. On December 10, the first batch of Chinese vaccines provided by the United Arab Emirates arrived in Egypt.
Turkey received the first 3 million doses of the Chinese-made new crown vaccine on 30 December 2020.
On 30 December 2020, Ukraine announced the purchase of 1.91 million doses of Sinovac Newcrown vaccine.
On December 31, 2020, Pakistan announced plans to purchase 1.2 million doses of the new crown vaccine from Sinopharmaceuticals.
On the same day, Myanmar announced that it would receive the Chinese-made vaccine in early 2021.
On January 3, 2021, Thailand announced the purchase of 2 million doses of Sinovac Sinovac vaccine.
On January 4, 2021, the Ministry of Health of Indonesia began to distribute Sinovac Sinovac vaccine nationwide.
Why do many countries around the world place their hopes on Chinese vaccines?
In the battle with Novel Coronavirus, vaccines are considered the “best hope.”
But the report from the People’s Alliance for Vaccines, an international body that monitors vaccines, reveals a harsh reality.
Although high-income countries account for only 14 per cent of the world’s population, they already purchase more than half of the world’s new crown vaccines.
In 67 low – and middle-income countries, including Kenya, Myanmar and Nigeria, only one in 10 people is “on track to be vaccinated by the end of 2021”.
China has officially joined the WHO’s “Covid-19 Vaccine Implementation Plan” and will consider providing vaccines to developing countries in various forms, including donations and grants.
Chinese vaccines could provide a lifeline to developing countries, The New York Times said.
The safety and effectiveness of Chinese vaccines have been recognized by many countries.
At the end of last year, Sinopharm’s China Bio-new crown inactivated vaccine was registered and marketed in the United Arab Emirates and Bahrain.
“The vaccine was 86 percent effective,” the United Arab Emirates health ministry announced.
Egyptian Health Minister Hala Zayed, who received the Sinopharm vaccine, affirmed its safety and effectiveness, saying “the new crown vaccine made in China is one of the best vaccines in the world,” the Egyptian Today reported.
China Sinovac new crown vaccine has also been recognized by many countries.
Turkish Health Minister Khoja said Sinovac’s new crown inactivated vaccine is effective and safe for the Turkish people.
Indonesia’s state-owned pharmaceutical company Bio Farma said data from a mid-stage trial of Sinovac’s new crown vaccine showed it was up to 97 percent effective, Reuters reported.
In China, inactivated vaccines are stored at 2-8 °C and are more widely available.
Osama Abdel-Haye, secretary general of the Egyptian Doctors’ Federation, said China’s new crown vaccine is safe, effective and easy to use.
Some countries have developed new nucleic acid vaccines that need to be stored at minus 70 degrees Celsius, and some vaccines need to be used within one to two weeks after production, he said. Some countries are unable to cope with the difficulties in production, transportation and storage.
Chinese vaccine sheds light on global fight against epidemic
CNN said China’s approval of the vaccine and the start of vaccination would pave the way for its large-scale rollout in China and around the world.
China’s approval of a Chinese drug vaccine brings the world one step closer to ending the Covid-19 epidemic, the BBC said.
Hong Kong-based South China Morning Post said the approval was a milestone for China.
The launch of the vaccine in China will provide a powerful weapon and inject more confidence into the fight against the epidemic.
The cold winter will be over, the dawn has emerged.